Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children
- PMID: 38064012
- PMCID: PMC10828005
- DOI: 10.1007/s12519-023-00777-9
Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children
Erratum in
-
Correction to: Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children.World J Pediatr. 2024 Feb 25. doi: 10.1007/s12519-023-00792-w. Online ahead of print. World J Pediatr. 2024. PMID: 38402517 No abstract available.
Abstract
Background: Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children.
Data sources: The evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using variations in terms for "respiratory syncytial virus", "RSV", "lower respiratory tract infection", "bronchiolitis", "acute", "viral pneumonia", "neonatal", "infant" "children", and "pediatric".
Results: Evidence-based recommendations regarding diagnosis, treatment, and prevention were proposed with a high degree of consensus. Although supportive care remains the cornerstone for the management of RSV infections, new monoclonal antibodies, vaccines, drug therapies, and viral surveillance techniques are being rolled out.
Conclusions: This consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points.
Keywords: Consensus prevention; Respiratory syncytial virus; Treatment.
© 2023. The Author(s).
Conflict of interest statement
Author Zhi-Min Chen is a member of the Editorial Board for
Similar articles
-
RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.J Med Virol. 2017 Jul;89(7):1151-1157. doi: 10.1002/jmv.24768. Epub 2017 Feb 24. J Med Virol. 2017. PMID: 28092107 Free PMC article.
-
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w. Ital J Pediatr. 2024. PMID: 38454523 Free PMC article.
-
Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.Lancet. 2024 Sep 21;404(10458):1143-1156. doi: 10.1016/S0140-6736(24)01716-1. Epub 2024 Sep 9. Lancet. 2024. PMID: 39265587 Review.
-
RSV disease in infants and young children: Can we see a brighter future?Hum Vaccin Immunother. 2022 Nov 30;18(4):2079322. doi: 10.1080/21645515.2022.2079322. Epub 2022 Jun 20. Hum Vaccin Immunother. 2022. PMID: 35724340 Free PMC article.
-
Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review.Curr Pediatr Rev. 2023;19(2):139-149. doi: 10.2174/1573396318666220810161945. Curr Pediatr Rev. 2023. PMID: 35950255 Review.
Cited by
-
[Urolithin A alleviates respiratory syncytial virus-induced lung infection in neonatal mice by activating miR-136-mediated Sirt1 signaling].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1370-1381. doi: 10.12122/j.issn.1673-4254.2024.07.17. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39051083 Free PMC article. Chinese.
-
Innovative biomarkers TCN2 and LY6E can significantly inhibit respiratory syncytial virus infection.J Transl Med. 2024 Sep 23;22(1):854. doi: 10.1186/s12967-024-05677-8. J Transl Med. 2024. PMID: 39313785 Free PMC article.
-
Retrospective Analysis of RSV Infection in Pediatric Patients: Epidemiology, Comorbidities, Treatment, and Costs in Dubai (2014-2023).J Health Econ Outcomes Res. 2024 Nov 5;11(2):133-144. doi: 10.36469/001c.123889. eCollection 2024. J Health Econ Outcomes Res. 2024. PMID: 39575134 Free PMC article.
-
[Two cases of neonatal Legionella pneumonia].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Sept 15;26(9):986-988. doi: 10.7499/j.issn.1008-8830.2405123. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 39267516 Free PMC article. Chinese.
-
The Impact of COVID-19 Pandemic on Respiratory Syncytial Virus Infection in Children.Pulm Med. 2024 Oct 18;2024:2131098. doi: 10.1155/2024/2131098. eCollection 2024. Pulm Med. 2024. PMID: 39464376 Free PMC article.
References
-
- Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. The Lancet. 2022;399:2047–2064. doi: 10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
-
- Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. The Lancet. 2017;390:946–958. doi: 10.1016/S0140-6736(17)30938-8. - DOI - PMC - PubMed
-
- Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao H, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23:56–66. doi: 10.1016/S1473-3099(22)00525-4. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical